Provided by Tiger Trade Technology Pte. Ltd.

California Resources

52.10
-0.2500-0.48%
Volume:226.25K
Turnover:11.78M
Market Cap:4.62B
PE:-37.11
High:52.53
Open:51.55
Low:51.40
Close:52.35
52wk High:71.98
52wk Low:43.25
Shares:88.60M
Float Shares:83.56M
Volume Ratio:0.43
T/O Rate:0.27%
Dividend:1.60
Dividend Rate:3.08%
EPS(TTM):-1.4038
EPS(LYR):4.15
ROE:-3.55%
ROA:0.76%
PB:1.36
PE(LYR):12.55

Loading ...

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

GlobeNewswire
·
Apr 22

Assessing California Resources (CRC) Valuation With Carbon Management Growth And Recent Share Price Momentum

Simply Wall St.
·
Apr 19

California Resources Amends Credit Facility to Cut Borrowing Costs

TIPRANKS
·
Apr 18

California Resources amends credit agreement with Citibank, cuts borrowing costs

Reuters
·
Apr 18

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

GlobeNewswire
·
Apr 18

Analysts Are Bullish on These Energy Stocks: California Resources Corp (CRC), W&T Offshore (WTI)

TIPRANKS
·
Apr 17

Press Release: Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board

Dow Jones
·
Apr 14

California Resources Is Maintained at Buy by UBS

Dow Jones
·
Apr 14

UBS Adjusts Price Target on California Resources Corp to $82 From $81, Maintains Buy Rating

MT Newswires Live
·
Apr 13

AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer

prnewswire
·
Apr 13

Analysts Offer Insights on Energy Companies: Precision Drilling (PDS) and California Resources Corp (CRC)

TIPRANKS
·
Apr 10

RBC Raises Price Target on California Resources to $87 From $70, Keeps Outperform Rating

MT Newswires Live
·
Apr 08

California Resources Corp (CRC) Receives a Buy from Barclays

TIPRANKS
·
Apr 07

California Resources schedules first-quarter 2026 earnings conference call

Reuters
·
Apr 06

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

GlobeNewswire
·
Apr 02

California Resources Is Maintained at Neutral by Citigroup

Dow Jones
·
Mar 31

Press Release: Harbour BioMed Reports Full Year 2025 Financial Results: Sustained Global Collaboration Underpins Long-Term Growth

Dow Jones
·
Mar 30

U.S. RESEARCH ROUNDUP- Ferguson Enterprises, Hartford Insurance Group, JP Morgan

Reuters
·
Mar 30

Citi Keeps Their Hold Rating on California Resources Corp (CRC)

TIPRANKS
·
Mar 30

Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

Dow Jones
·
Mar 26